These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 115193)
21. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests. Nortier JW; Croughs RJ; Thijssen JH; Schwarz F Clin Endocrinol (Oxf); 1984 May; 20(5):565-71. PubMed ID: 6744634 [TBL] [Abstract][Full Text] [Related]
22. Bromocriptine therapy in acromegaly. Sachdev Y; Gomez-Pan A; Tunbridge WM; Duns A; Weightman DR; Hall R; Goolamali SK Lancet; 1975 Dec; 2(7946):1164-8. PubMed ID: 53655 [TBL] [Abstract][Full Text] [Related]
23. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly. Demura R; Yamaguchi H; Demura H; Shizume K Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371 [TBL] [Abstract][Full Text] [Related]
24. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly. Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344 [TBL] [Abstract][Full Text] [Related]
25. Bromocriptine reduces growth hormone in acromegaly. Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102 [TBL] [Abstract][Full Text] [Related]
26. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
27. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)]. Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332 [TBL] [Abstract][Full Text] [Related]
28. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly. Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191 [TBL] [Abstract][Full Text] [Related]
29. Experiences with bromocriptine treatment in acromegaly--a preliminary report. Nilsson A Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038 [TBL] [Abstract][Full Text] [Related]
30. Bromocriptine therapy in acromegaly. A long-term review of 35 cases. Sachdev Y; Gopal K; Garg VK Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229 [TBL] [Abstract][Full Text] [Related]
31. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine. Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861 [TBL] [Abstract][Full Text] [Related]
32. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C. Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607 [TBL] [Abstract][Full Text] [Related]
33. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly. Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013 [TBL] [Abstract][Full Text] [Related]
34. Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients. Fedele D; Molinari M; Meneghel A; Valerio A; Muggeo M; Tiengo A J Endocrinol Invest; 1980; 3(2):149-53. PubMed ID: 6993548 [TBL] [Abstract][Full Text] [Related]
35. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine. Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270 [TBL] [Abstract][Full Text] [Related]
36. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response. Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567 [TBL] [Abstract][Full Text] [Related]
37. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients. Ishibashi M; Yamaji T; Kosaka K J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240 [TBL] [Abstract][Full Text] [Related]
38. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy. Pelkonen R; Ylikahri R; Karonen SL Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053 [TBL] [Abstract][Full Text] [Related]
39. Sleep-related growth hormone release following 2-bromo-alpha-ergocriptine treatment in acromegalic patients. Chihara K; Kato Y; Abe H; Furumoto M; Maeda K J Clin Endocrinol Metab; 1977 Jan; 44(1):78-84. PubMed ID: 576232 [TBL] [Abstract][Full Text] [Related]